Aclarion, Inc. SEC filings ACONW

Aclarion, Inc. has 276 filings in SEC EDGAR's recent list, going back to Mar 3, 2015. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jun 4, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

Aclarion, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jul 9, 2026 —
424B5 Prospectus supplement Jan 9, 2026 —
424B5 Prospectus supplement Oct 14, 2025 —
S-3 Shelf registration Apr 25, 2025 —
424B5 Prospectus supplement Jan 31, 2025 —
424B4 Prospectus Jan 16, 2025 —
S-1MEF Registration statement Jan 14, 2025 —
S-1/A Amended registration statement Jan 10, 2025 —
424B5 Prospectus supplement Jan 6, 2025 —
S-1/A Amended registration statement Dec 26, 2024 —
S-1 Registration statement Dec 11, 2024 —
424B3 Prospectus Nov 8, 2024 —
424B3 Prospectus Nov 5, 2024 —
424B3 Prospectus Nov 5, 2024 —
S-3 Shelf registration Nov 4, 2024 —
S-1 Registration statement Oct 25, 2024 —
POS AM Post effective amendment no. 2 to form s-1 Oct 11, 2024 —
424B5 Prospectus supplement Sep 24, 2024 —
S-3/A Form s-3 amendment 1 Sep 19, 2024 —
POS AM Post effective amendment no. 1 to form s-1 Sep 9, 2024 —
S-3 Shelf registration Sep 9, 2024 —
424B4 Prospectus Feb 27, 2024 —
S-1/A Amended registration statement Feb 23, 2024 —
S-1/A Amended registration statement Feb 21, 2024 —
S-1/A Amended registration statement Feb 6, 2024 —
424B3 Prospectus Feb 1, 2024 —
S-1/A Amended registration statement Jan 31, 2024 —
S-1 Registration statement Jan 22, 2024 —
424B3 Prospectus Jan 4, 2024 —
S-1 Registration statement Dec 11, 2023 —
424B3 Prospectus Nov 16, 2023 —
424B3 Prospectus Oct 23, 2023 —
424B3 Prospectus Oct 23, 2023 —
S-1/A Amended registration statement Oct 20, 2023 —
S-1 Registration statement Oct 10, 2023 —
424B3 Prospectus Jul 14, 2023 —
S-1/A Amended registration statement Jul 12, 2023 —
S-1 Registration statement Jul 3, 2023 —
S-8 Employee stock plan registration May 26, 2022 —
424B4 Prospectus Apr 25, 2022 —
S-1/A Amended registration statement Apr 20, 2022 —
S-1/A Amended registration statement Apr 19, 2022 —
S-1/A Amended registration statement Apr 1, 2022 —
S-1/A Amended registration statement Mar 23, 2022 —
S-1/A Amended registration statement Mar 4, 2022 —
S-1 Registration statement Jan 6, 2022 —

Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
ACON (Nasdaq), ACONW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Broomfield, CO
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1635077
Former names
Nocimed, Inc. (until Oct 26, 2021)

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.